Advertisement

Pacritinib Well Tolerated and Helpful in Myelofibrosis

Compared with the best available therapy for myelofibrosis, pacritinib significantly reduces spleen volume and curbs symptoms, according to results from the PERSIST-1 trial. 

 Medscape Oncology